Reporte zur Charge 06984AA/U5872AA

Symptomtext

patient received an expired dose of Adacel with no reported adverse event; Initial information received on 09-Dec-2021 regarding an unsolicited valid non-serious case received from a consumer/non-hcp (healthcare professional). This case involves a 22-years-old male patient who received an expired dose of adacel with no reported adverse event while receiving vaccine diphtheria-2/tetanus/5 ac pertussis vaccine [Adacel]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 09-Mar-2022, the patient received a dose of 0.5 mL of suspect diphtheria-2/tetanus/5 ac pertussis vaccine Suspension for injection once (lot U5872AA/:06984AA; 02-Feb-2022 and 18-Mar-2023) via intramuscular route in the right deltoid as prophylactic vaccination. On 09-MAR-2022 the patient developed a non-serious event "patient received an expired dose of adacel with no reported adverse event" (expired product administered) (latency: same day) following the administration of DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE. Action taken: Not applicable. Corrective treatment: Not reported Outcome: Unknown for expired product administered. Additional information was received on 09-Mar-2022 from consumer/non-hcp: Case updated to non-serious case from non-case.